Premium
Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity‐modulated chemoradiation
Author(s) -
Broglie Martina A.,
Soltermann Alex,
Rohrbach David,
Haile Sarah R.,
Pawlita Michael,
Studer Gabriela,
Huber Gerard F.,
Moch Holger,
Stoeckli Sandro J.
Publication year - 2013
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.23231
Subject(s) - medicine , oncology , tissue microarray , multivariate analysis , immunohistochemistry , head and neck squamous cell carcinoma , basal cell , prospective cohort study , surrogate endpoint , radiation therapy , survival analysis , head and neck cancer
Background Analysis of the impact of risk factors on survival in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated by primary intensity‐modulated radiotherapy (IMRT). Methods One hundred forty patients were included with tissue microarray (TMA) construction and immunohistochemical analysis in 124 patients (87%). Results Survival analysis of patients classified into 3 risk categories according to an algorithm based on p16, smoking, T classification, and N classification revealed significant differences with a low, intermediate, and high‐risk group. There was a significant impact of p53 expression as surrogate marker for smoking on outcome. In multivariate analysis, p16‐positivity was a positive predictor and alcohol as well as N classification was a negative predictor for survival. The algorithm was modified based on alcohol instead of smoking with even more significant differences between the groups. Conclusions A risk model based on multiple factors instead of p16 as single marker can define different risk groups to select patients for treatment deintensification in future prospective clinical trials. © 2013 Wiley Periodicals, Inc. Head Neck 35: 1698–1706, 2013